Bente Smagge
YOU?
Author Swipe
View article: COVID-19 vaccine effectiveness against hospitalisation in the Netherlands, 2021: Improved stratified estimates
COVID-19 vaccine effectiveness against hospitalisation in the Netherlands, 2021: Improved stratified estimates Open
View article: Determinants for not keeping up to date with COVID-19 vaccination among medical risk groups
Determinants for not keeping up to date with COVID-19 vaccination among medical risk groups Open
Vaccination is critical for preventing severe COVID-19 in medical risk groups (MRG). However, coverage has sharply declined among MRG in the Netherlands, from 19% in 2022 to 6% in 2023 (18-59 years) and from 61% to 53% (≥60 years). Underst…
View article: Determinants for not keeping up to date with COVID-19 vaccination in the 2023 vaccination round among medical risk groups, the Netherlands
Determinants for not keeping up to date with COVID-19 vaccination in the 2023 vaccination round among medical risk groups, the Netherlands Open
COVID-19 vaccine coverage among MRG in the Netherlands declined in 2023 compared to 2022. We identified several determinants for dropout, which are relevant for program optimization.
View article: Covid-19 Vaccine Effectiveness Against Hospitalisation in the Netherlands, 2021: Improved Stratified Estimates
Covid-19 Vaccine Effectiveness Against Hospitalisation in the Netherlands, 2021: Improved Stratified Estimates Open
View article: Factors associated with lower COVID-19 vaccine uptake among populations with a migration background in the Netherlands
Factors associated with lower COVID-19 vaccine uptake among populations with a migration background in the Netherlands Open
Lower COVID-19 vaccination coverage was observed among some populations with a migration background in the Netherlands. This study examined determinants of being unvaccinated against COVID-19 in the primary vaccination round in adults and …
View article: Factors associated with lower COVID-19 vaccine uptake among populations with a migration background in the Netherlands
Factors associated with lower COVID-19 vaccine uptake among populations with a migration background in the Netherlands Open
Background In high income countries, the incidence of severe COVID-19 has been disproportionally high among persons with a migration background. We examined determinants of being unvaccinated against COVID-19 in the Netherlands among four …
View article: Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalisation and admission to intensive care, the Netherlands, 9 October to 5 December 2023
Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalisation and admission to intensive care, the Netherlands, 9 October to 5 December 2023 Open
We present early vaccine effectiveness (VE) estimates of the 2023 seasonal COVID-19 XBB.1.5 vaccine against COVID-19 hospitalisation and admission to an intensive care unit (ICU) in previously vaccinated adults ≥ 60 years in the Netherland…
View article: Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalization and ICU admission, the Netherlands, 9 October - 5 December 2023
Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalization and ICU admission, the Netherlands, 9 October - 5 December 2023 Open
We present early vaccine effectiveness (VE) estimates of the 2023 seasonal COVID-19 vaccination campaign using XBB.1.5 vaccine against COVID-19 hospitalization and ICU admission in previously vaccinated adults ≥60 years old in the Netherla…
View article: Determinants of COVID-19 vaccine uptake in the Netherlands: A nationwide registry-based study
Determinants of COVID-19 vaccine uptake in the Netherlands: A nationwide registry-based study Open
Introduction By September 2022, uptake of at least one dose of COVID-19 vaccine in the Dutch adult population was 84%. Ecological studies indicated lower uptake in certain population groups. We aimed to investigate determinants of COVID-19…
View article: Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study
Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study Open
By September 2022, the uptake of at least one dose of COVID-19 vaccine in the Dutch adult population was 84%. Ecological studies have indicated a lower uptake in certain population groups. We aimed to investigate determinants of COVID-19 v…
View article: Determinants of COVID-19 vaccine uptake in the Netherlands: a nationwide registry-based study
Determinants of COVID-19 vaccine uptake in the Netherlands: a nationwide registry-based study Open
By September 2022, uptake of at least one dose of COVID-19 vaccine in the Dutch adult population was 84%. Ecological studies have indicated lower uptake in certain population groups. We aimed to investigate determinants of COVID-19 vaccine…
View article: Determinants of COVID-19 booster uptake in the Netherlands, autumn 2022: how well were those at risk for severe disease reached?
Determinants of COVID-19 booster uptake in the Netherlands, autumn 2022: how well were those at risk for severe disease reached? Open
Background A booster with bivalent COVID-19 vaccine was offered in the Netherlands in autumn, 2022. We aimed to investigate vaccine uptake during the autumn 2022 booster round among the population subgroups at risk for severe COVID-19 that…
View article: Urban density differences in colorectal cancer screening participation and screening yield in The Netherlands
Urban density differences in colorectal cancer screening participation and screening yield in The Netherlands Open
Lower socioeconomic status has been associated with higher colorectal cancer incidence and lower participation in population-based screening with faecal immunochemical testing (FIT) but regional variations in participation may also exist. …